Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022 | ||
By: GlobeNewswire - 23 May 2022 | Back to overview list |
|
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its combined general meeting on June 28, 2022 at 2:30 p.m. CET at the Company's offices at 8 rue de la Croix Jarry (4th floor) 75013 Paris, France. The notice announcing the General Meeting details the agenda and modalities of participation for the meeting, and will be made available on the Company’s website: https://cellectis.com/en/investors/general-meetings/ About Cellectis For more information, visit www.cellectis.com For further information, please contact: Media contacts: Investor Relation contact: Attachment |
||
|
||
Copyright 2022 GlobeNewswire | Back to overview list |